Pharma & Healthcare
Global Sitagliptin Metformin Extended Release Tablets Market Research Report 2026
- Feb 24, 26
- ID: 719783
- Pages: 109
- Figures: 112
- Views: 2
This report delivers a comprehensive overview of the global Sitagliptin Metformin Extended Release Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sitagliptin Metformin Extended Release Tablets. The Sitagliptin Metformin Extended Release Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sitagliptin Metformin Extended Release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sitagliptin Metformin Extended Release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Jiangsu Anbisheng Pharmaceutical Co., Ltd.
Jiangsu Xuantai Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group
Merck & Co., Inc.
Abbott
Sandoz Pty Ltd
Segment by Type
Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sitagliptin Metformin Extended Release Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sitagliptin Metformin Extended Release Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Sitagliptin Metformin Extended Release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sitagliptin Metformin Extended Release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Jiangsu Anbisheng Pharmaceutical Co., Ltd.
Jiangsu Xuantai Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group
Merck & Co., Inc.
Abbott
Sandoz Pty Ltd
Segment by Type
Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sitagliptin Metformin Extended Release Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sitagliptin Metformin Extended Release Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Sitagliptin Metformin Extended Release Tablets Market Overview
1.1 Product Definition
1.2 Sitagliptin Metformin Extended Release Tablets by Type
1.2.1 Global Sitagliptin Metformin Extended Release Tablets Market Value by Type: 2025 vs 2032
1.2.2 Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
1.2.3 Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
1.3 Sitagliptin Metformin Extended Release Tablets by Application
1.3.1 Global Sitagliptin Metformin Extended Release Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Sitagliptin Metformin Extended Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Sitagliptin Metformin Extended Release Tablets Revenue 2021–2032
1.4.2 Global Sitagliptin Metformin Extended Release Tablets Sales 2021–2032
1.4.3 Global Sitagliptin Metformin Extended Release Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Sitagliptin Metformin Extended Release Tablets Market Competition by Manufacturers
2.1 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Sitagliptin Metformin Extended Release Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Sitagliptin Metformin Extended Release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Date of Entry into the Industry
2.8 Global Sitagliptin Metformin Extended Release Tablets Market Competitive Situation and Trends
2.8.1 Global Sitagliptin Metformin Extended Release Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Sitagliptin Metformin Extended Release Tablets Players Market Share by Revenue
2.8.3 Global Sitagliptin Metformin Extended Release Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sitagliptin Metformin Extended Release Tablets Market Scenario by Region
3.1 Global Sitagliptin Metformin Extended Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2021–2032
3.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2021–2026
3.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2027–2032
3.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021–2032
3.3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021–2026
3.3.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2027–2032
3.4 North America Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country
3.4.1 North America Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)
3.4.3 North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country
3.5.1 Europe Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)
3.5.3 Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Sitagliptin Metformin Extended Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)
3.7.3 Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021–2032)
4.1.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021–2026)
4.1.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2027–2032)
4.1.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021–2032)
4.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021–2032)
4.2.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021–2026)
4.2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2027–2032)
4.2.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Sitagliptin Metformin Extended Release Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021–2032)
5.1.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021–2026)
5.1.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2027–2032)
5.1.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021–2032)
5.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021–2032)
5.2.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021–2026)
5.2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2027–2032)
5.2.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Sitagliptin Metformin Extended Release Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd.
6.1.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Company Information
6.1.2 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.1.5 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Jiangsu Xuantai Pharmaceutical Co., Ltd.
6.2.1 Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information
6.2.2 Jiangsu Xuantai Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.2.5 Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Chia Tai Tianqing Pharmaceutical Group
6.3.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.3.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.3.3 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.3.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.4 Merck & Co., Inc.
6.4.1 Merck & Co., Inc. Company Information
6.4.2 Merck & Co., Inc. Description and Business Overview
6.4.3 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.4.5 Merck & Co., Inc. Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Abbott Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Sandoz Pty Ltd
6.6.1 Sandoz Pty Ltd Company Information
6.6.2 Sandoz Pty Ltd Description and Business Overview
6.6.3 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.6.5 Sandoz Pty Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sitagliptin Metformin Extended Release Tablets Industry Chain Analysis
7.2 Sitagliptin Metformin Extended Release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sitagliptin Metformin Extended Release Tablets Production Mode & Process Analysis
7.4 Sitagliptin Metformin Extended Release Tablets Sales and Marketing
7.4.1 Sitagliptin Metformin Extended Release Tablets Sales Channels
7.4.2 Sitagliptin Metformin Extended Release Tablets Distributors
7.5 Sitagliptin Metformin Extended Release Tablets Customer Analysis
8 Sitagliptin Metformin Extended Release Tablets Market Dynamics
8.1 Sitagliptin Metformin Extended Release Tablets Industry Trends
8.2 Sitagliptin Metformin Extended Release Tablets Market Drivers
8.3 Sitagliptin Metformin Extended Release Tablets Market Challenges
8.4 Sitagliptin Metformin Extended Release Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Sitagliptin Metformin Extended Release Tablets by Type
1.2.1 Global Sitagliptin Metformin Extended Release Tablets Market Value by Type: 2025 vs 2032
1.2.2 Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
1.2.3 Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
1.3 Sitagliptin Metformin Extended Release Tablets by Application
1.3.1 Global Sitagliptin Metformin Extended Release Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Sitagliptin Metformin Extended Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Sitagliptin Metformin Extended Release Tablets Revenue 2021–2032
1.4.2 Global Sitagliptin Metformin Extended Release Tablets Sales 2021–2032
1.4.3 Global Sitagliptin Metformin Extended Release Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Sitagliptin Metformin Extended Release Tablets Market Competition by Manufacturers
2.1 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Sitagliptin Metformin Extended Release Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Sitagliptin Metformin Extended Release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Date of Entry into the Industry
2.8 Global Sitagliptin Metformin Extended Release Tablets Market Competitive Situation and Trends
2.8.1 Global Sitagliptin Metformin Extended Release Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Sitagliptin Metformin Extended Release Tablets Players Market Share by Revenue
2.8.3 Global Sitagliptin Metformin Extended Release Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sitagliptin Metformin Extended Release Tablets Market Scenario by Region
3.1 Global Sitagliptin Metformin Extended Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2021–2032
3.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2021–2026
3.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2027–2032
3.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021–2032
3.3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021–2026
3.3.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2027–2032
3.4 North America Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country
3.4.1 North America Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)
3.4.3 North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country
3.5.1 Europe Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)
3.5.3 Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Sitagliptin Metformin Extended Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)
3.7.3 Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021–2032)
4.1.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021–2026)
4.1.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2027–2032)
4.1.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021–2032)
4.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021–2032)
4.2.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021–2026)
4.2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2027–2032)
4.2.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Sitagliptin Metformin Extended Release Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021–2032)
5.1.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021–2026)
5.1.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2027–2032)
5.1.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021–2032)
5.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021–2032)
5.2.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021–2026)
5.2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2027–2032)
5.2.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Sitagliptin Metformin Extended Release Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd.
6.1.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Company Information
6.1.2 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.1.5 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Jiangsu Xuantai Pharmaceutical Co., Ltd.
6.2.1 Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information
6.2.2 Jiangsu Xuantai Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.2.5 Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Chia Tai Tianqing Pharmaceutical Group
6.3.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.3.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.3.3 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.3.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.4 Merck & Co., Inc.
6.4.1 Merck & Co., Inc. Company Information
6.4.2 Merck & Co., Inc. Description and Business Overview
6.4.3 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.4.5 Merck & Co., Inc. Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Abbott Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Sandoz Pty Ltd
6.6.1 Sandoz Pty Ltd Company Information
6.6.2 Sandoz Pty Ltd Description and Business Overview
6.6.3 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product Portfolio
6.6.5 Sandoz Pty Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sitagliptin Metformin Extended Release Tablets Industry Chain Analysis
7.2 Sitagliptin Metformin Extended Release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sitagliptin Metformin Extended Release Tablets Production Mode & Process Analysis
7.4 Sitagliptin Metformin Extended Release Tablets Sales and Marketing
7.4.1 Sitagliptin Metformin Extended Release Tablets Sales Channels
7.4.2 Sitagliptin Metformin Extended Release Tablets Distributors
7.5 Sitagliptin Metformin Extended Release Tablets Customer Analysis
8 Sitagliptin Metformin Extended Release Tablets Market Dynamics
8.1 Sitagliptin Metformin Extended Release Tablets Industry Trends
8.2 Sitagliptin Metformin Extended Release Tablets Market Drivers
8.3 Sitagliptin Metformin Extended Release Tablets Market Challenges
8.4 Sitagliptin Metformin Extended Release Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Sitagliptin Metformin Extended Release Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Sitagliptin Metformin Extended Release Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Sitagliptin Metformin Extended Release Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Sitagliptin Metformin Extended Release Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Sitagliptin Metformin Extended Release Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Sitagliptin Metformin Extended Release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sitagliptin Metformin Extended Release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sitagliptin Metformin Extended Release Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sitagliptin Metformin Extended Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Company Information
Table 71. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product
Table 74. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information
Table 76. Jiangsu Xuantai Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product
Table 79. Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Chia Tai Tianqing Pharmaceutical Group Company Information
Table 81. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
Table 82. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product
Table 84. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 85. Merck & Co., Inc. Company Information
Table 86. Merck & Co., Inc. Description and Business Overview
Table 87. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product
Table 89. Merck & Co., Inc. Recent Developments/Updates
Table 90. Abbott Company Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Abbott Sitagliptin Metformin Extended Release Tablets Product
Table 94. Abbott Recent Developments/Updates
Table 95. Sandoz Pty Ltd Company Information
Table 96. Sandoz Pty Ltd Description and Business Overview
Table 97. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product
Table 99. Sandoz Pty Ltd Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Sitagliptin Metformin Extended Release Tablets Distributors List
Table 103. Sitagliptin Metformin Extended Release Tablets Customers List
Table 104. Sitagliptin Metformin Extended Release Tablets Market Trends
Table 105. Sitagliptin Metformin Extended Release Tablets Market Drivers
Table 106. Sitagliptin Metformin Extended Release Tablets Market Challenges
Table 107. Sitagliptin Metformin Extended Release Tablets Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sitagliptin Metformin Extended Release Tablets
Figure 2. Global Sitagliptin Metformin Extended Release Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Sitagliptin Metformin Extended Release Tablets Market Share by Type: 2025 & 2032
Figure 4. Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg Product Picture
Figure 5. Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg Product Picture
Figure 6. Global Sitagliptin Metformin Extended Release Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Sitagliptin Metformin Extended Release Tablets Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Sitagliptin Metformin Extended Release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Sitagliptin Metformin Extended Release Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units), 2021–2032
Figure 14. Global Sitagliptin Metformin Extended Release Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Sitagliptin Metformin Extended Release Tablets Report Years Considered
Figure 16. Sitagliptin Metformin Extended Release Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Sitagliptin Metformin Extended Release Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Sitagliptin Metformin Extended Release Tablets Players: Market Share by Revenue in Sitagliptin Metformin Extended Release Tablets in 2025
Figure 19. Sitagliptin Metformin Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Sitagliptin Metformin Extended Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Sitagliptin Metformin Extended Release Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Sitagliptin Metformin Extended Release Tablets by Type (2021–2032)
Figure 54. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Sitagliptin Metformin Extended Release Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Sitagliptin Metformin Extended Release Tablets by Application (2021–2032)
Figure 57. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Sitagliptin Metformin Extended Release Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Sitagliptin Metformin Extended Release Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Sitagliptin Metformin Extended Release Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Sitagliptin Metformin Extended Release Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Sitagliptin Metformin Extended Release Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Sitagliptin Metformin Extended Release Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Sitagliptin Metformin Extended Release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sitagliptin Metformin Extended Release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sitagliptin Metformin Extended Release Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sitagliptin Metformin Extended Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Company Information
Table 71. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product
Table 74. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information
Table 76. Jiangsu Xuantai Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product
Table 79. Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Chia Tai Tianqing Pharmaceutical Group Company Information
Table 81. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
Table 82. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product
Table 84. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 85. Merck & Co., Inc. Company Information
Table 86. Merck & Co., Inc. Description and Business Overview
Table 87. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product
Table 89. Merck & Co., Inc. Recent Developments/Updates
Table 90. Abbott Company Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Abbott Sitagliptin Metformin Extended Release Tablets Product
Table 94. Abbott Recent Developments/Updates
Table 95. Sandoz Pty Ltd Company Information
Table 96. Sandoz Pty Ltd Description and Business Overview
Table 97. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product
Table 99. Sandoz Pty Ltd Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Sitagliptin Metformin Extended Release Tablets Distributors List
Table 103. Sitagliptin Metformin Extended Release Tablets Customers List
Table 104. Sitagliptin Metformin Extended Release Tablets Market Trends
Table 105. Sitagliptin Metformin Extended Release Tablets Market Drivers
Table 106. Sitagliptin Metformin Extended Release Tablets Market Challenges
Table 107. Sitagliptin Metformin Extended Release Tablets Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sitagliptin Metformin Extended Release Tablets
Figure 2. Global Sitagliptin Metformin Extended Release Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Sitagliptin Metformin Extended Release Tablets Market Share by Type: 2025 & 2032
Figure 4. Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg Product Picture
Figure 5. Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg Product Picture
Figure 6. Global Sitagliptin Metformin Extended Release Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Sitagliptin Metformin Extended Release Tablets Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Sitagliptin Metformin Extended Release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Sitagliptin Metformin Extended Release Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units), 2021–2032
Figure 14. Global Sitagliptin Metformin Extended Release Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Sitagliptin Metformin Extended Release Tablets Report Years Considered
Figure 16. Sitagliptin Metformin Extended Release Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Sitagliptin Metformin Extended Release Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Sitagliptin Metformin Extended Release Tablets Players: Market Share by Revenue in Sitagliptin Metformin Extended Release Tablets in 2025
Figure 19. Sitagliptin Metformin Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Sitagliptin Metformin Extended Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Sitagliptin Metformin Extended Release Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Sitagliptin Metformin Extended Release Tablets by Type (2021–2032)
Figure 54. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Sitagliptin Metformin Extended Release Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Sitagliptin Metformin Extended Release Tablets by Application (2021–2032)
Figure 57. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Sitagliptin Metformin Extended Release Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232